Abstract:Objectives This study was designed to assess the clinical course and to identify risk factors for life-threatening events in patients with long-QT syndrome (LQTS) with normal corrected QT (QTc) intervals.Background Current data regarding the outcome of patients with concealed LQTS are limited.Methods Clinical and genetic risk factors for aborted cardiac arrest (ACA) or sudden cardiac death (SCD) from birth through age 40 years were examined in 3,386 genotyped subjects from 7 multinational LQTS registries, categorized as LQTS with normal-range QTc (<= 440 ms [n = 469]), LQTS with prolonged QTc interval (>440 ms [ n = 1,392]), and unaffected family members (genotyped negative with <= 440 ms [ n = 1,525]).Results The cumulative probability of ACA or SCD in patients with LQTS with normal-range QTc intervals (4%) was significantly lower than in those with prolonged QTc intervals (15%) (p < 0.001) but higher than in unaffected family members (0.4%) (p < 0.001). Risk factors ACA or SCD in patients with normal-range QTc intervals included mutation characteristics (transmembrane-missense vs. nontransmembrane or nonmissense mutations: hazard ratio: 6.32; p = 0.006) and the LQTS genotypes (LQTS type 1: LQTS type 2, hazard ratio: 9.88; p = 0.03; LQTS type 3: LQTS type 2, hazard ratio: 8.04; p = 0.07), whereas clinical factors, including sex and QTc duration, were associated with a significant increase in the risk for ACA or SCD only in patients with prolonged QTc intervals (female age >13 years, hazard ratio: 1.90; p = 0.002; QTc duration, 8% risk increase per 10-ms increment; p = 0.002).Conclusions Genotype-confirmed patients with concealed LQTS make up about 25% of the at-risk LQTS population. Genetic data, including information regarding mutation characteristics and the LQTS genotype, identify increased risk for ACA or SCD in this overall lower risk LQTS subgroup. (J Am Coll Cardiol 2011;57:51-9) (C) 2011 by the American College of Cardiology Foundation

Latent Genetic Backgrounds and Molecular Pathogenesis in Acquired Long Qt Syndrome with Distinct Arrhythmic Triggers

The Genetics Underlying Acquired Long QT Syndrome: Impact for Genetic Screening

Risk for Life-Threatening Cardiac Events in Patients with Genotype-Confirmed Long-Qt Syndrome and Normal-Range Corrected QT Intervals.

Clinical Aspects of Type-1 Long-Qt Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene.

Prognostic Implications of Mutation-Specific QTc Standard Deviation in Congenital Long QT Syndrome.

Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Α-1-syntrophin Mutation and the Long-QT Syndrome

Identification of A Kir3.4 Mutation in Congenital Long Qt Syndrome

Clinical Course And Risk Stratification Of Patients Affected With The Jervell And Lange-Nielsen Syndrome

Molecular Pathogenesis of Long QT Syndrome Type 1.

Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan

Clinical and Genetic Characteristics of 18 Cases with Suspected Congenital Long QT Syndrome: A Retrospective Cross-Sectional Study

[Novel Mutations of Potassium Channel KCNQ1 S145L and KCNH2 Y475C Genes in Chinese Pedigrees of Long QT Syndrome].

Unraveling Complexities in Genetically Elusive Long QT Syndrome

Genetics, Molecular Mechanisms and Management of Long QT Syndrome

From genes to clinical management: A comprehensive review of long QT syndrome pathogenesis and treatment

Spectrum of ST-T–Wave Patterns and Repolarization Parameters in Congenital Long-QT Syndrome

Clinical Characters and Mutation Analysis of Potassium Channel Genes KCNH2 in 77 Pedigrees of Chinese with Long QT Syndrome

Mutation Analysis of Potassium Channel Genes KCNQ1 and KCNH2 in Patients with Long QT Syndrome

Long QT Syndrome Diagnosed by Genetic Analysis in Six Pedigress